Analysis of Multimorbidity of Moderate to Severe Allergic Rhinitis in Children: A Real-World Study

Zheng Gu1, Ping Wei2, Wei Kou2

  • 1Department of Otolaryngology Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing Key Laboratory of Child Infection and Immunity, Chongqing, China, 403730416@qq.com.

Insights

Allergic rhinitis in children often presents with other conditions. Key risk factors for these multimorbidities include family allergy history, young age, and cesarean birth.

Area of Science:

  • Pediatrics
  • Allergology
  • Epidemiology

Background:

  • Allergic rhinitis (AR) in children frequently co-occurs with other health issues, complicating management.
  • Limited research exists on multimorbidities in Chinese children with AR.

Purpose of the Study:

  • To determine the prevalence of multimorbidities in Chinese children with moderate to severe AR.
  • To identify factors influencing these multimorbidities.

Main Methods:

  • Prospective enrollment of 600 children diagnosed with moderate-severe AR.
  • Data collection via questionnaires, allergen testing, and nasopharyngoscopy.
  • Investigated comorbidities: atopic dermatitis, asthma, allergic conjunctivitis, etc.

Main Results:

  • High prevalence of recurrent epistaxis (46.5%), allergic conjunctivitis (46.3%), and atopic dermatitis (40.7%).
  • Risk factors identified: younger age (<6 years), family allergy history, cesarean section, and specific allergen sensitivities (dust mites).
  • Familial history of allergy, younger age, cesarean section, and allergen type were independent risk factors for various comorbidities.

Conclusions:

  • AR in children is associated with numerous allergic and non-allergic comorbidities.
  • Age, family history of allergy, allergen type, and mode of delivery are significant risk factors for AR multimorbidities.
Abstract

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Allergic Reactions02:06

Allergic Reactions

Overview
27.9K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
462
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
358